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Introduction
Over the past decades, multiple centers have initiated surveil-
lance programs in individuals at high risk of developing pancre-
atic ductal adenocarcinoma (PDAC) to evaluate the diagnostic
yield of such surveillance programs and ultimately improve
poor survival of PDAC [1–13]. As recommended by the Cancer
of the Pancreas Screening (CAPS) Consortium, most surveil-
lance programs entail annual magnetic resonance imaging
(MRI) as well as endoscopic ultrasound (EUS) imaging of the
pancreas [14]. The diagnostic yield for detection of high-grade
dysplastic precursor lesions (i. e., pancreatic intraductal neopla-
sia (PanIN)-3 and intraductal papillary mucinous neoplasms
(IPMN) with high-grade dysplasia) or early stage PDAC varies
between studies with an overall diagnostic yield of about 10%
[15].
During EUS-based PDAC surveillance, cystic or solid lesions
can be detected and features of chronic pancreatitis (CP) also
are frequently observed. The clinical significance of these CP
features in asymptomatic individuals is still unclear. Research
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ABSTRACT
Background and study aims During endoscopic ultra-
sound (EUS)-based pancreatic ductal adenocarcinoma
(PDAC)-surveillance in asymptomatic individuals, features
of chronic pancreatitis (CP) are often detected. Little is
known about the prevalence and progression of these fea-
tures. The aim of this study was to quantify these features,
assess the interobserver agreement, assess possible asso-
ciated factors, and assess the natural course during 3 years
of follow-up.
Patients and methods Two experienced endosonogra-
phers reviewed anonymized sequential EUS videos of parti-
cipants in PDAC surveillance that were obtained in 2012
and 2015 for features of CP. Descriptives, agreement analy-
ses, univariate and multivariate analyses for possible risk
factors, and repeated measures analyses to assess intra-in-
dividual changes over time were performed.
Results A total of 42 EUS videos of 21 participants were re-
viewed. Any feature of CP was present in 86% (2012) and
81% (2015) of participants, with a mean of 2.5 features
per individual. The overall interobserver agreement was al-
most perfect at 83%. No baseline factors were significantly
associated with features of CP. Features did not change over
time, except for hyperechoic foci without shadowing, which
decreased intra-individually (β=–1.6, P=0.005).
Conclusions This blinded study shows features of CP to be
highly prevalent in individuals at high risk of developing
pancreatic cancer. No baseline factors were associated
with presence of these features. CP features did not in-
crease intra-individually over a 3-year period. Longer fol-
low-up and pathological examination of pancreatic resec-
tion specimens will be essential to learn whether EUS detec-
tion and follow-up of these CP features bear clinical rele-
vance.
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suggests that these features might be related to emerging Pa-
nIN and IPMN lesions [16, 17], however, little is known about
the prevalence and progression of these CP features detected
in asymptomatic high-risk individuals. Therefore, the aim of
this study was to quantify CP features in individuals participat-
ing in our EUS/MRI-based surveillance program by reviewing
stored videos of sequential EUS examinations and assess their
progress over a 3-year period. We also aimed to study interob-
server agreement in our series and assess possible factors asso-
ciated with presence of these CP features.
Patients and methods
Our PDAC surveillance program has been described in detail be-
fore [13]. In summary, annual surveillance is performed using
EUS and MRI/MRCP in individuals at inherited or familial in-
creased risk of developing PDAC (≥10% life-time risk, i. e. all
carriers of CDKN2A gene mutations, all Peutz-Jeghers syndrome
patients, carriers of gene mutations in BRCA1, BRCA2, TP53 or
mismatch repair genes with a family history of PDAC in at least
two family members, and first-degree relatives of patients with
familial pancreatic cancer [FPC]). All EUS-investigations are per-
formed under conscious sedation with midazolam/fentanyl by
experienced endosonographers using a curvilinear device. Ima-
ges of the pancreas are obtained from the duodenum and
stomach and are digitally recorded in real time with lossy com-
pression.
For this study, all participants in PDAC surveillance at the
Erasmus University Medical Center Rotterdam, The Nether-
lands, were included for whom two EUS videos were available
3 years apart (2012 and 2015). The images were anonymized
for patient ID and date of investigation. Two highly experienced
endosonographers (MB and JWP, each over 3500 career EUS in-
vestigations) individually reassessed the videos for features of
CP: parenchymal features [18] were scored in the head, body
and tail of the pancreas and ductal features [18] were scored
in the body and tail, using a standardized Case Record Form.
The EUS videos were randomly assigned a video number and
were thus assessed in an order for which no correlation could
be made between patient ID or date of investigation. Both en-
dosonographers scored the videos separately, after which a
consensus meeting was held to discuss individuals in whom
there was a difference in scored features.
The study was approved by the local Ethical Committee and
was conducted in accordance with the Declaration of Helsinki.
All participants provided written informed consent prior to per-
formance of any study procedures.
Statistical methods
Descriptive statistics were used to describe participants’ char-
acteristics. A proportion of agreement was calculated to assess
interobserver agreement for each feature of CP. We considered
an agreement of 0.00 as poor, 0.01–0.20 as slight, 0.21–0.40
as fair, 0.41–0.60 as moderate, 0.61–0.80 as substantial and
0.81–0.99 as almost perfect agreement and 1.00 as perfect
agreement [19].
Data after consensus agreement were analyzed using de-
scriptive statistics and univariate (Chi-square test, Fisher’s ex-
act test and independent t-test where appropriate) and multi-
variate analyses, to detect participants’ characteristics asso-
ciated with a mean of ≥4 CP features on EUS assessments. In-
tra-individual changes over time were assessed with repeated
measures, generalized estimated equations for ordinal out-
comes, and with mixed-effect models (growth curve models)
with maximum likelihood estimator and unstructured covar-
iance matrix for longitudinal data (non-proportional analyses).
To correct for multiple testing, we only report P values < 0.01 as
statistically significant. For all statistical analyses, the Statistical
Package for the Social Sciences was used (version 23.0, SPSS In-
stitute, Chicago, IL).
Results
Participant characteristics
In 2012, EUS videos of 26 individuals participating in surveil-
lance were stored, of whom 21 individuals had a follow-up EUS
video available in 2015. These 21 individuals were included in
the study and their characteristics are summarized in ▶Table 1.
The mean age of the 21 included individuals was 52, they were
predominantly female and there were no excessive alcohol con-
sumers or diabetic participants.
Review of the first EUS video showed any feature of chronic
pancreatitis in 18 of 21 (86%) participants, and in 17 (81%) at
review of the second video, 3 years later (as specified in ▶Ta-
ble 2). The mean number of CP features per participant was
2.5 (range 0–7). When the Rosemont classification [18] was
applied, only 52% of screened individuals had a normal EUS ex-
amination and three (7%) fulfilled criteria for CP.
Interobserver agreement
Results of the interobserver agreement analyses are shown in
▶Table3. On almost all CP features, there was an almost per-
fect to perfect agreement between the two reviewers. Sub-
stantial agreement was reached for hyperechoic foci without
shadowing overall (69% agreement), in the head (69% agree-
ment) and in the tail of the pancreas (79% agreement)), for lo-
bularity without honeycombing overall (71% agreement) and in
the body of the pancreas (71% agreement), and for hyperecho-
ic main pancreatic duct margins overall (71% agreement), and
in the body of the pancreas (79% agreement). Only moderate
agreement was reached for stranding overall, and in the head
of the pancreas (59.5 and 52.4% agreement, respectively).
Agreement for all CP features (taken together, all possible CP
features in any location of the pancreas, i. e. the 29 items from
▶Table3) rated as almost perfect at 83%.
Characteristics associated with features of chronic
pancreatitis
▶Table4 shows the results of univariate and multivariate ana-
lyses regarding possible risk factors associated with detection
of a mean of ≥4 features of CP on EUS.On univariate analysis,
“age of the youngest relative affected by PDAC” was the only
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identified risk factor (P=0.002), but it was not sustained after
multivariate analysis.
Intra-individual change in detected features of
chronic pancreatitis
Results of the repeated measures generalized estimated equa-
tions analyses of intra-individual change in CP features are
shown in ▶Table2. Except for hyperechoic foci without sha-
dowing, which decreased intra-individually (overall (β=–1.6,
standard error [SE] 0.6, P=0.006) and, more specifically, in the
head of the pancreas (β=–2.1, SE 0.7, P=0.005), CP features
did not change in the 3 years. Also, the mean number of CP fea-
tures and the Rosemont classification did not change. However,
there was one individual, a 60-year-old woman without a
known gene mutation (FPC), in whom in 2012 only 1 feature of
CP was present (a cyst in the head of the pancreas), while in
2015, no less than 7 features were detected (hyperechoic foci
with and without shadowing, lobularity with and without hon-
eycombing, stranding, MPD calculi, and hyperechoic MPD mar-
gins) (▶Fig. 1). Unfortunately, this patient subsequently died of
trauma.
None of the individuals in this series underwent surgery be-
tween 2012 and 2015.One individual, a 50-year-old male with-
out a known gene mutation (FPC), had already undergone a dis-
tal pancreatectomy in 2011 as a consequence of two EUS-de-
tected solid lesions. Prior to surgery, no features of CP were de-
tected. The resection specimen harbored a panIN-2 lesion and
diffuse foci with panIN-1B. The EUS videos of the remnant pan-
creas from 2012 and 2015 showed hyperechoic foci without
shadowing and hyperechoic MPD margins in 2012; in 2015
only, stranding was detected.
▶ Table 1 Baseline characteristics of included individuals.
All individuals included in the study (n=21)
N (%)
Sex, male 4 (19%)
Age at inclusion (years), mean (range, SD) 52 (41–68, 7.1)
Body Mass Index, mean (range, SD) 26 (16–40, 5.4)
Underlying gene mutation
▪ CDKN2Amutation 6 (29%)
▪ BRCA2mutation 1 (5%)
▪ LKB1/STK11mutation 1 (5%)
▪ Unknown (FPC) 13 (62%)
No. of relatives affected by PDAC, mean (range, SD) 2 (0–6, 1.5)
Age of youngest relative affected by PDAC, mean (range, SD) 50 (42–72, 9.1)
Diabetes 0 (0%)
Smoking
▪ Current smoker 3 (14%)
▪ Past smoker 3 (14%)
▪ Never smoker 15 (71%)
▪ ≥20 pack years of smoking 3 (14%)
Alcohol consuming
▪ Current alcohol consumer 16 (76%)
▪ Current excessive alcohol consumer (≥3 units/day) 0 (0%)
▪ Past alcohol consumer 1 (5%)
▪ Past excessive alcohol consumer (≥3 units/day) 0 (0%)
▪ Never alcohol consumer 4 (19%)
Features of chronic pancreatitis
▪ Individuals with features present at first available EUS video 18 (86%)
▪ Individuals with features present at second available EUS video 17 (81%)
SD, standard deviation; FPC, familial pancreatic cancer; PDAC, pancreatic ductal adenocarcinoma; EUS, endoscopic ultrasound.
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▶ Table 2 Overview of detected features of chronic pancreatitis.
Features of chronic pancreatitis All available EUS
videos (n=42)
First available
EUS video
(2012, n=21)
Second available
EUS video
(2015, n=21)
Intra-individual change
(2012 vs 2015)
Β SE P
Hyperechoic foci with shadowing
▪ Head
▪ Body
▪ Tail
3 (7 %)
1 (2%)
3 (7%)
2 (5%)
2 (10%)
0 (0%)
2 (10%)
1 (5%)
1 (5%)
1 (5%)
1 (5%)
1 (5%)
–0.74
–
–0.74
–
1.3
–
1.3
–
0.570
–
0.570
1.000
Hyperechoic foci without shadowing
▪ Head
▪ Body
▪ Tail
20 (48%)
15 (36%)
10 (24%)
8 (19%)
14 (67%)
12 (57%)
8 (38%)
5 (24%)
6 (29%)
3 (14%)
2 (10%)
3 (14%)
–1.61
–2.08
–1.77
–0.63
0.6
0.7
0.8
0.8
0.006
0.005
0.035
0.414
Lobularity with honeycombing
▪ Head
▪ Body
▪ Tail
5 (12%)
1 (2%)
5 (12%)
4 (10%)
3 (14%)
1 (5%)
3 (14%)
2 (10%)
2 (10%)
0 (0%)
2 (10%)
2 (10%)
–0.46
–
–0.46
–
0.8
–
0.8
–
0.564
–
0.564
1.000
Lobularity without honeycombing
▪ Head
▪ Body
▪ Tail
13 (31%)
6 (14%)
7 (17%)
6 (14%)
8 (38%)
4 (19%)
5 (24%)
2 (10%)
5 (24%)
2 (10%)
2 (10%)
4 (19%)
–0.68
–0.80
–1.09
0.80
0.6
0.8
1.0
0.8
0.251
0.318
0.265
0.318
Cysts
▪ Head
▪ Body
▪ Tail
9 (21%)
5 (12%)
5 (12%)
5 (12%)
5 (24%)
2 (10%)
3 (14%)
3 (14%)
4 (19%)
3 (14%)
2 (10%)
2 (10%)
–0.28
0.46
–0.46
–0.46
0.8
1.0
0.8
0.8
0.705
0.656
0.564
0.564
Stranding
▪ Head
▪ Body
▪ Tail
30 (71%)
26 (61%)
15 (36%)
12 (29%)
14 (67%)
12 (57%)
6 (29%)
5 (24%)
16 (76%)
14 (67%)
9 (43%)
7 (33%)
0.47
0.41
0.63
0.47
0.6
0.6
0.5
0.6
0.411
0.477
0.167
0.411
MPD calculi
▪ Head
▪ Body
▪ Tail
1 (2 %)
1 (2%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
1 (5%)
1 (5%)
0 (0%)
0 (0%)
–
–
–
–
–
–
–
–
–
–
–
–
Irregular MPD contour
▪ Body
▪ Tail
0 (0 %)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
–
–
–
–
–
–
–
–
–
Dilated side branches
▪ Body
▪ Tail
5 (12%)
2 (5%)
5 (12%)
2 (10%)
1 (5%)
2 (10%)
3 (14%)
1 (5%)
3 (14%)
0.46
–
0.46
0.8
–
0.8
0.564
1.000
0.564
MPD dilatation
▪ Body
▪ Tail
1 (2 %)
0 (0%)
1 (2%)
0 (0%)
0 (0%)
0 (0%)
1 (5%)
0 (0%)
1 (5%)
–
–
–
–
–
–
–
–
–
Hyperechoic MPD margin
▪ Body
▪ Tail
15 (36%)
14 (33%)
8 (19%)
8 (38%)
7 (33%)
4 (19%)
7 (33%)
7 (33%)
4 (19%)
–0.21
–
–
0.6
–
–
0.739
1.000
1.000
Mean number of features of CP (range, SD) 2.5 (0–7, 1.5) 2.7 (0–5, 1.4) 2.2 (0–7, 2.2) –0.43 0.4 0.328
Rosemont classification
▪ Normal
▪ Indeterminate for CP
▪ Suggestive of CP
▪ Consistent with CP
22 (52%)
13 (31%)
4 (10%)
3 (7%)
9 (43%)
7 (33%)
3 (14%)
2 (10%)
13 (62%)
6 (29%)
1 (5%)
1 (5%)
0.956
4.4 0.029
EUS, endoscopic ultrasound; MPD, main pancreatic duct; SE, standard error.
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Discussion
This study shows CP features to be highly prevalent in asympto-
matic participants in PDAC surveillance, with a substantial to al-
most perfect interobserver agreement. Also, these features
hardly changed over a 3-year course of follow-up.
Since the start of our PDAC surveillance program in 2008,
features of CP were often detected, but their clinical relevance
was unclear. They have been associated with incipient or emer-
ging PanIN and IPMN lesions producing lobular parenchymal
atrophy resulting in CP-like changes [16, 17]. Therefore, to as-
sess detection of features of CP, interobserver agreement for
these features, factors associated with them, and above all,
the natural course of these features over time during EUS-
based surveillance for PDAC in high-risk individuals, we con-
ducted this blinded single-center study in which we reviewed
stored videos from EUS examinations in 2012 and 2015.
In our series, we showed CP features to be highly prevalent:
86% (in 2012) and 81% (in 2015) of individuals had an EUS fea-
ture of CP; only 52% of individuals fell into the category “nor-
▶ Table 3 Interobserver agreement per feature of chronic pancreatitis.
Features of chronic pancreatitis % agreement between two reviewers Interpretation of % agreement
Hyperechoic foci with shadowing
▪ Head
▪ Body
▪ Tail
85.7
90.5
88.1
95.2
Almost perfect agreement
Almost perfect agreement
Almost perfect agreement
Almost perfect agreement
Hyperechoic foci without shadowing
▪ Head
▪ Body
▪ Tail
69.0
69.0
85.7
78.6
Substantial agreement
Substantial agreement
Almost perfect agreement
Substantial agreement
Lobularity with honeycombing
▪ Head
▪ Body
▪ Tail
88.1
97.6
88.1
88.1
Almost perfect agreement
Almost perfect agreement
Almost perfect agreement
Almost perfect agreement
Lobularity without honeycombing
▪ Head
▪ Body
▪ Tail
71.4
83.3
71.4
83.3
Substantial agreement
Almost perfect agreement
Substantial agreement
Almost perfect agreement
Cysts
▪ Head
▪ Body
▪ Tail
92.9
95.2
92.9
85.7
Almost perfect agreement
Almost perfect agreement
Almost perfect agreement
Almost perfect agreement
Stranding
▪ Head
▪ Body
▪ Tail
59.5
52.4
83.3
85.7
Moderate agreement
Moderate agreement
Almost perfect agreement
Almost perfect agreement
MPD calculi
▪ Head
▪ Body
▪ Tail
100.0
100.0
100.0
100.0
Perfect agreement
Perfect agreement
Perfect agreement
Perfect agreement
Irregular MPD contour
▪ Body
▪ Tail
97.6
100.0
97.6
Almost perfect agreement
Perfect agreement
Almost perfect agreement
Dilated side branches
▪ Body
▪ Tail
83.3
92.9
88.1
Almost perfect agreement
Almost perfect agreement
Almost perfect agreement
MPD dilatation
▪ Body
▪ Tail
97.6
100.0
97.6
Almost perfect agreement
Perfect agreement
Almost perfect agreement
Hyperechoic MPD margin
▪ Body
▪ Tail
71.4
78.6
83.3
Substantial agreement
Substantial agreement
Almost perfect agreement
Overall (taken together all 29 items above) 83.3 Almost perfect agreement
MPD, main pancreatic duct.
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mal” when the Rosemont classification [18] was applied. This
prevalence is much higher than described in a non-high-risk co-
hort. Petrone et al. [20] described 16.8% of asymptomatic indi-
viduals undergoing EUS for an indication not related to pan-
creatico-biliary disease as having at least one ductal or parench-
ymal abnormality present. As the prevalence of CP features in
our cohort at high risk of developing PDAC is this high, the al-
leged association between (progression) of specific EUS fea-
tures and presence of PanIN or IPMN lesions bears particular in-
terest.
Assessing the intra-individual change in CP features over our
3-year study period, the number of CP features, individual CP
features and Rosemont classification did not change, except
for a statistically significant intra-individual decrease in hypere-
choic foci without shadowing. However, development and pro-
gression of precursor lesions into PDAC may take multiple years
[21]. Continued follow-up of these individuals therefore is of pi-
votal importance. Eventually, pathological examination of re-
sected pancreatic specimens, not yet available from individuals
in the current study, are needed to further clarify the associa-
tion and clinical relevance of EUS detection of CP features.
Our study revealed no baseline factors significantly associat-
ed with detection of a mean of ≥4 CP features. Even factors that
are known to be associated with CP, including smoking and al-
cohol consumption [22, 23], were not associated with detec-
tion of CP features in our cohort. Although speculative, this
could be related to the underlying pathophysiologic mecha-
nism of chronic pancreatitis-like changes in individuals at high
risk of developing pancreatic cancer. Studies suggest that (mul-
tifocal) PanIN and IPMN lesions produce obstructive lobular
atrophy or the pancreatic parenchyma which is likely the source
of the CP-like changes that follow in these patients [16, 17].
▶ Table 4 Univariate and multivariate analyses for factors possibly associated with a mean≥4 features of chronic pancreatitis
Factors Univariate analyses
P value
Multivariate analysis
P value
Sex 0.546 0.999
Age 0.504 0.625
Body mass index 0.646
Underlying gene mutation 0.890
Number of relatives affected by PDAC 0.388 0.938
Age of youngest relative affected by PDAC 0.002 0.367
Smoking 0.574
Number of pack years of smoking 0.371 0.677
Alcohol consuming 0.849
Number of alcohol units per week 0.691
PDAC, pancreatic ductal adenocarcinoma.
▶ Fig. 1 Serial still images of endosonography in a participant with marked progression of features of chronic pancreatitis. a Still image of the
endoscopic ultrasound examination in 2012, showing an unremarkable pancreas. b Still image of the endoscopic ultrasound examination in
2015 in the same individual, showing multiple features of chronic pancreatitis (hyperechoic foci, lobularity, stranding, and a hyperechoic main
pancreatic duct margin).
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Our analyses into interobserver agreement for detection of
CP features showed an excellent agreement for most of the CP
features. Overall agreement between the two expert endoso-
nographers was 83% and rated as almost perfect. This is some-
what better than described in previous reports where a moder-
ate to substantial agreement was described [24–26] (kappa-
values of 0.46, 0.65 and agreement of 68%, respectively). Our
high interobserver agreement might be explained by the fact
that our two reviewers are highly trained and experienced en-
dosonographers.
To our knowledge, this is the first study to longitudinally as-
sess features of CP in asymptomatic high-risk individuals parti-
cipating in an EUS-based PDAC surveillance program. Another
strength of this study is that two expert endosonographers re-
viewed the EUS recordings in a blinded fashion using a stand-
ardized case record form. However, this study also has some
limitations. The number of participants was limited and the fol-
low-up comprised 3 years. None of the participating individuals
underwent surgery and we therefore lack definite diagnoses
and pathological correlates. Consequently, it is not possible to
determine the clinical relevance of the different EUS features of
CP that were detected. Also, the Rosement classification was
applied in our cohort. This classification was not designed for
the purpose of diagnosing CP in asymptomatic patients at high
risk of developing PDAC. Although individual criteria can be
readily applied and followed in an asymptomatic cohort of
high-risk individuals undergoing PDAC surveillance, its clinical
relevance in this setting remains unclear. The total score also
may be less relevant than development of individual features
over time.
Conclusion
In conclusion, this blinded study, reviewing EUS videos of
asymptomatic high-risk individuals participating in EUS-based
PDAC surveillance, showed features of CP to be highly prevalent
but stable over a 3-year period, with high interobserver agree-
ment. We could not associate any baseline factors with detec-
tion of these CP features. Longer follow-up and, if available,
pathological examination of pancreatic resection specimens
will be essential to understanding the relationship between
these CP features and development of malignancy, and wheth-
er detection of these features bears clinical relevance, for ex-
ample, in setting the indication for resection or serving as a cri-
terion of influence in determining the screening interval.
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